Paediatrician human resource planning in Canada: A 10-year follow-up

Jamie A Seabrook1, Victoria Cukiernik, Doreen Matsui

  • 1Departments of Paediatrics and.

Insights

Canadian paediatrician demographics shifted towards an older, more female workforce between 1987 and 1997. Despite workforce changes, paediatrician shortages in rural areas persist, impacting child care.

Area of Science:

  • Medical Workforce Analysis
  • Paediatrician Demographics
  • Healthcare Planning

Background:

  • Canadian paediatrician human resource planning faces significant challenges.
  • Optimal physician practice mix and geographical distribution remain debated.

Purpose of the Study:

  • To analyze 10-year trends (1987-1997) in Canadian paediatric practice.
  • To compare changes in paediatrician age, sex, and tertiary care practice.

Main Methods:

  • Utilized national survey data from 1987 and 1997 on Canadian paediatricians.
  • Examined demographic and practice pattern information.

Main Results:

  • The percentage of female paediatricians increased from 26.2% to 38.5%.
  • The proportion of paediatricians aged 25-34 decreased significantly.
  • Tertiary care practice remained stable, but these specialists concentrated in larger urban areas.

Conclusions:

  • The Canadian paediatric workforce is aging, increasingly female, and concentrated in urban centers.
  • Persistent shortages of paediatricians in rural and remote areas remain a critical concern.
  • Future assessment of the impact on child-care service delivery and quality is necessary.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...